Ardelyx (ARDX) Announces FDA Approval of XPHOZAH
Go back to Ardelyx (ARDX) Announces FDA Approval of XPHOZAH| Oppenheimer Rising Dividends Fund, Inc. Class A (NASDAQ: ARDX) | Delayed: 3.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.76 | 52 Week High | $20.98 | |||
| Open | $3.76 | 52 Week Low | $6.36 | |||
| Day High | $3.76 | P/E | N/A | |||
| Day Low | $3.76 | EPS | $0.00 | |||
| Volume | 200 | |||||
